MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
MTNB — Matinas BioPharma Holdings, Inc.
NYSE AmericanMatinas BioPharma Holdings, Inc.
$3.01
+0.19(+6.74%)
- O
- 2.76
- H
- 3.15
- L
- 2.64
- V
- 356.75K
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About MTNB
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJul 21, 2014
Employees2
Stock ExchangeNYSE American
Ticker SymbolMTNB
Key Financial Statistics
| Market Cap | $2.59M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.15 - $3.15 |
| 52-Week Avg Volume | 1.24M |
| VWAP | $2.99 |
| Transactions | 2,526 |
| Total Recorded Bars | 3,072 days |